2022
DOI: 10.1016/j.yexmp.2022.104763
|View full text |Cite
|
Sign up to set email alerts
|

Antihyperglycemic activity of L-norvaline and L-arginine in high-fat diet and streptozotocin-treated male rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 64 publications
0
3
0
Order By: Relevance
“…In the future, advancing knowledge on the ability of simple dipeptides to form supramolecular hydrophilic channels may assist their design for insertion into biological membranes, for instance, towards therapeutic effects [47][48][49]. Further scope for applications of Nva-bearing dipeptides may also arise as current studies are revealing new beneficial effects from the administration of this amino acid in diverse pathological settings, spanning from neurodegeneration to hypertension [50][51][52][53][54].…”
Section: Discussionmentioning
confidence: 99%
“…In the future, advancing knowledge on the ability of simple dipeptides to form supramolecular hydrophilic channels may assist their design for insertion into biological membranes, for instance, towards therapeutic effects [47][48][49]. Further scope for applications of Nva-bearing dipeptides may also arise as current studies are revealing new beneficial effects from the administration of this amino acid in diverse pathological settings, spanning from neurodegeneration to hypertension [50][51][52][53][54].…”
Section: Discussionmentioning
confidence: 99%
“…Following this, the cells were counterstained with hematoxylin, immersed in 1% ammonia, and stained with eosin, before being rewashed with PBS. Images were then obtained using a light microscope (Optika IM3, Italy) (Javrushyan et al, 2022). 2 7.The preparation of the samples for determination of arginase activity, and changes in NO and MDA quantity Arginase and NO activity, as well as changes in MDA quantity, were analyzed in HeLa and A549 cells treated with AgNPs.…”
Section: Mtt Cytotoxicity Assaymentioning
confidence: 99%
“…Increase in the local levels of nitric oxide in humans and responsiveness to L-arginine as a nitric oxide precursor [33] Patients with fibrosis and severe secondary Raynaud's phenomenon phenotypes at L-arginine-based therapies 1-2 g/day-10 g/day NO metabolism in fibrosis and severe secondary Raynaud's phenomenon phenotypes eNOS, iNOS [34] Patients with primary or secondary Raynaud's phenomenon at L-arginine-based therapy Endothelial-derived mediators Increased nitric oxide synthesis [35] Review of data from animal and clinical studies Analysis of the states of hypertension, diabetes, hypercholesterolaemia, and vascular inflammation L-arginine improved treatment of cardiovascular disorders via the NO pathway [36] Rats with high-fat diet and streptozotocin-induced hyperglycaemia, arginase inhibition (via L-norvaline) and supplementation (via L-arginine) L-arginine acted as a potent antihyperglycaemic agent Inhibition of arginase provided an antihyperglycaemic effect, NO protected against oxidative stress and hypercholesterolaemia [37] Patients with acute coronary syndrome, myocardial infarction and metabolic syndrome, L-arginine (4.2 g)/L-carnitine (2.0 g) in infusions for 28 days…”
Section: Improved Endothelial Dysfunction By L-arginine Supplementationmentioning
confidence: 99%